GlassScriptPhysician profile
Lindsey Renae Schwaderer
NPI 1073027314
$837.61
in general payments reported to CMS, 2019-2025
12 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $254 · 2023: $217 · 2024: $246 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $584.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $583.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $148.90 | 2021-2024 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $138.69 | 2023-2025 | Farxiga |
| Boston Scientific Corporation | $138.58 | 2021-2024 | Watchman Flx |
| Regeneron Healthcare Solutions, INC. | $117.18 | 2023 | Evkeeza |
| Novartis Pharmaceuticals Corporation | $96.95 | 2023-2025 | |
| Amgen INC. | $54.21 | 2024 | Repatha |
| Alnylam Pharmaceuticals INC. | $40.35 | 2021-2025 | Amvuttra |
| E.R. Squibb & Sons, L.L.C. | $24.74 | 2025 | Camzyos |
| Abbott Laboratories | $23.08 | 2024 | Cardiomems |
| Merck Sharp & Dohme LLC | $19.76 | 2024 | Winrevair |
| Novo Nordisk INC | $18.26 | 2024 | Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $16.91 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lindsey Schwaderer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.